Clinical Trials
7 trialsNCT04458259 2026-06-04
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Pfizer
Phase 1 Terminated
NCT04000529 2025-09-30
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Novartis
Phase 1 Terminated
NCT04135352 2024-11-12
V938-001
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT03833427 2024-11-07
MK-5618-001
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT03739138 2022-02-28
MK-4621-002
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT03515824 2021-03-09
MK-1697-001
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT03099161 2019-06-05
MK-3814A-062
Merck Sharp & Dohme LLC
Phase 1 Terminated